通过系统地挖掘大规模数据集来调查JAK抑制和静脉血栓塞栓症之间的关联
Stine Rabech Haysen1, Ane Langkilde-Lauesen Nielsen1, Per Qvist1,2
1Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Inflammopharmacology
|February 24, 2025
概括
失调的简氏激酶信号转换器和转录激活器 (STAT) 信号传输与静脉血栓栓塞 (VTE) 有关. 这项研究揭示了JAK-STAT通路中的基因组漏洞,这些漏洞有助于VTE的发病.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 血液学 血液学 血液学
背景情况:
- 简氏激酶抑制剂 (JAKi) 与静脉血栓栓塞 (VTE) 风险的增加有关.
- 了解VTE中的JAK-STAT信号对于风险分层和药物开发至关重要.
研究的目的:
- 调查VTE中对失调的JAK-STAT信号的基因组脆弱性.
- 分析JAK-STAT通路基因与VTE病变的关联.
主要方法:
- 系统地挖掘大规模数据集,比较VTE患者和健康对照.
- 在VTE中评估JAK-STAT通路实体 (miRNA,mRNA,蛋白质).
- 探索JAK-STAT信号基因组与VTE的累积遗传关联.
主要成果:
- 在VTE患者中,JAK-STAT通路中的基因发生了显著的改变.
- 在VTE中下调基因中,STAT标基因过度代表.
- STAT转录因子结合部位富含着差异调节的基因促进体.
- 通过差异调节的miRNA向的基因被STAT向和JAK-STAT通路基因丰富.
结论:
- 在JAK-STAT通路中发生的干扰有助于VTE的分子概况.
- 研究结果表明,针对JAK-STAT途径的潜在治疗策略可以降低VTE风险.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
593
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
593
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
Drug Binding to Blood Components
102
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
102
Statistical Methods for Analyzing Epidemiological Data
284
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
284


